We outline the market outlook for patient data & analytics in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
What is patient data & analytics?
Patient data & analytics companies provide anonymized patient genomic datasets and supporting analytical tools, such as genomic variant analysis software, to fuel drug target discovery and patient stratification. Many solutions also incorporate other data sources, such as electronic health records and transcriptomic and proteomic data.
<![endif]-->
<script charset="utf-8" type="text/javascript" src=https://www.cbinsights.com/research/market-trend-report-patient-data-analytics-pharma-cro-leaders/"//js.hsforms.net/forms/v2.js">
<script>
hbspt.forms.create({
onFormReady: function ($form) {
window.ClearbitForHubspot.addForm($form);
},
region: "na1",
portalId: "763793",
formId: "90955808-0135-4f5d-b9bc-c9c16290b2f4"
});
</script></div></div></div>"}" data-sheets-userformat="{"2":6657,"3":{"1":0},"12":0,"14":{"1":2,"2":4473924},"15":"Arial"}">FREE DOWNLOAD: THE COMPLETE DIGITAL HEALTH 150 LIST
Features & capabilities
Patient data & analytics solutions provide pharma and clinical research organization (CRO) leaders with several capabilities, including the following:
- Multi-omics data management
- Next-generation sequencing (NGS) analysis platforms
- Artificial intelligence (AI)-based real-world applications
- Machine-learning-based predictive analytics
- Clinico-genomic databases
Want the full expert post? Become a CB Insights customer.
If you’re already a customer, log in here.
